- Home
- MRNS vs ISDR Comparison
MRNS vs ISDR Comparison
Compare MRNS & ISDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNS
- ISDR
- Stock Information
- Founded
- MRNS 2003
- ISDR 1988
- Country
- MRNS United States
- ISDR United States
- Employees
- MRNS N/A
- ISDR N/A
- Industry
- MRNS Biotechnology: Pharmaceutical Preparations
- ISDR Publishing
- Sector
- MRNS Health Care
- ISDR Consumer Discretionary
- Exchange
- MRNS Nasdaq
- ISDR Nasdaq
- Market Cap
- MRNS 29.9M
- ISDR 35.0M
- IPO Year
- MRNS 2014
- ISDR N/A
- Fundamental
- Price
- MRNS $0.54
- ISDR $9.30
- Analyst Decision
- MRNS Buy
- ISDR
- Analyst Count
- MRNS 12
- ISDR 0
- Target Price
- MRNS $4.28
- ISDR N/A
- AVG Volume (30 Days)
- MRNS 3.2M
- ISDR 15.0K
- Earning Date
- MRNS 03-04-2025
- ISDR 03-06-2025
- Dividend Yield
- MRNS N/A
- ISDR N/A
- EPS Growth
- MRNS N/A
- ISDR N/A
- EPS
- MRNS N/A
- ISDR N/A
- Revenue
- MRNS $31,466,000.00
- ISDR $29,141,000.00
- Revenue This Year
- MRNS $14.97
- ISDR N/A
- Revenue Next Year
- MRNS $57.65
- ISDR N/A
- P/E Ratio
- MRNS N/A
- ISDR N/A
- Revenue Growth
- MRNS 1.63
- ISDR N/A
- 52 Week Low
- MRNS $0.22
- ISDR $7.61
- 52 Week High
- MRNS $10.50
- ISDR $16.92
- Technical
- Relative Strength Index (RSI)
- MRNS 70.29
- ISDR 53.39
- Support Level
- MRNS $0.54
- ISDR $8.26
- Resistance Level
- MRNS $0.56
- ISDR $8.89
- Average True Range (ATR)
- MRNS 0.02
- ISDR 0.49
- MACD
- MRNS 0.01
- ISDR 0.06
- Stochastic Oscillator
- MRNS 93.71
- ISDR 78.79
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
About ISDR Issuer Direct Corporation
Issuer Direct Corp is a communications and compliance company. It focuses on the needs of corporate issuers. It provides disclosure management solutions, shareholder communications tools, and cloud-based compliance technologies. Its customers include public and private companies, mutual funds, law firms, brokerage firms, investment banks, individuals, and other institutions. Its products include PR solutions, IR solutions, Compliance, and Event management software.